United Lincolnshire Hospitals NHS Trust (ULHT) has joined the fight against coronavirus by recruiting COVID-19 patients to participate in a ground-breaking new study.
The study, performed by the partnership between the GenOMICC Study Consortium (led by the University of Edinburgh), and announced by the Secretary of State for Health and Social Care, Matt Hancock, hopes to better understand the virus’ varied effects on people and support the search for treatments.
The data collected by the Trust and others will be compared to that from a further 15,000 COVID-19 patients who experienced only mild symptoms.
This 'ground-breaking' research may help explain why some patients with COVID-19 experience a mild infection, others require intensive care and why for some it is sadly fatal. By discovering why some people are predisposed to developing life-threatening symptoms, the initiative aims to enable insights into the virus, as well as possible human factors that influence the effects of the disease.
ULHT has already recruited 14 patients to the study, and is aiming to recruit more.